A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate

Autor: Lousada-Dietrich, Susana1,2,3, Jogdand, Prajakta S.1,2,3, Jepsen, Søren1, Pinto, Vera V.2,3, Ditlev, Sisse B.2,3, Christiansen, Michael1, Larsen, Severin Olesen1, Fox, Christopher B.4, Raman, Vanitha S.4, Howard, Randall F.4, Vedvick, Thomas S.4, Ireton, Gregory4, Carter, Darrick4, Reed, Steven G.4, Theisen, Michael1,2,3 mth@ssi.dk
Zdroj: Vaccine. Apr2011, Vol. 29 Issue 17, p3284-3292. 9p.
Databáze: Academic Search Ultimate
Externí odkaz: